Stevens R H, Lillard S E, Hammond B F
Infect Immun. 1987 Mar;55(3):692-7. doi: 10.1128/iai.55.3.692-697.1987.
Extracts of certain strains of Actinobacillus actinomycetemcomitans are inhibitory to strains of Streptococcus sanguis such as S. sanguis ATCC 10556. The isolation of a protein from an A. actinomycetemcomitans sonic extract which copurified with the inhibitory activity was accomplished by preparative isoelectric focusing, Sephadex G-100 gel filtration chromatography, and preparative polyacrylamide gel electrophoresis (PAGE). The resulting isolated protein, which focused at a pH of 6.1 to 6.3, appeared as a single band in anionic nondissociating PAGE analysis. This protein could be dissociated into two subunits with molecular weights of 50,000 and 70,000, which were resolvable by PAGE analysis. A 1,758-fold increase in specific activity was seen in the purified inhibitory protein compared with the crude sonic extract starting material. The properties of the inhibitory activity in the A. actinomycetemcomitans extract are characteristic of a bacteriocin. Accordingly, we propose the name actinobacillicin for the inhibitory protein.
某些伴放线放线杆菌菌株的提取物对血链球菌菌株(如血链球菌ATCC 10556)具有抑制作用。通过制备性等电聚焦、Sephadex G - 100凝胶过滤色谱和制备性聚丙烯酰胺凝胶电泳(PAGE),从伴放线放线杆菌超声提取物中分离出一种与抑制活性共纯化的蛋白质。所得分离的蛋白质在pH 6.1至6.3聚焦,在阴离子非解离PAGE分析中呈现为单一条带。该蛋白质可解离为两个分子量分别为50,000和70,000的亚基,通过PAGE分析可分辨。与粗超声提取物起始材料相比,纯化的抑制性蛋白质的比活性增加了1758倍。伴放线放线杆菌提取物中抑制活性的特性是细菌素的特征。因此,我们提议将该抑制性蛋白质命名为放线杆菌素。